KINTOR PHARMA-B(09939): Completion of the sale of 20.67 million shares, with old shares being sold before new shares.

KINTOR PHARMA-B (09939) announced that the placement matters were completed on August 5, 2025 in accordance with the terms and conditions of the agreement. The placement agent successfully placed a total of 20.673 million shares of placement shares to not less than six underwriters at a placement price of HK$2.08 per share. The directors, after conducting all reasonable inquiries, are informed, well-informed, and convinced that the underwriters and their ultimate beneficial owners are independent of the company or its affiliates and have no connection with them. As all conditions for subscription have been met, the company has, on August 14, 2025, in accordance with the terms and conditions of the agreement, issued and allotted 20.673 million subscription shares to the seller at a subscription price of HK$2.08 per share (equivalent to the placement price).